Acceptability of a PrEP program for MSM and transgender individuals
Easy-Tests Study: Acceptability of a PrEP Program Among MSM and TG Visiting a Geolocated Community Application or a Community Physical Place of Sociability and Having Accepted a Targeted Screening for HIV, Hepatitis B, C and STIs.
This study is trying to see if a new program for taking HIV prevention medication is accepted by men who have sex with men and transgender individuals who use community apps or spaces.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre de santé sexuelle Le 190 Academic / other |
| Locations | 1 site (Paris, Île-de-France) |
| Trial ID | NCT05949814 on ClinicalTrials.gov |
What this trial studies
This study evaluates the acceptability of a pre-exposure prophylaxis (PrEP) program among men who have sex with men (MSM) and transgender individuals who engage with a community application or visit a sociable community space. Participants will undergo targeted screenings for HIV, Hepatitis B, Hepatitis C, and other sexually transmitted infections (STIs). The study aims to identify innovative strategies to enhance screening and prevention efforts in populations that are less likely to seek care. By focusing on these key populations, the research seeks to address the ongoing public health challenge of HIV infections in France.
Who should consider this trial
Good fit: Ideal candidates include cisgender men, transgender men, and transgender women aged 18 and older who are willing to participate in STI screenings.
Not a fit: Patients who are planning to stay in France for less than one month or those under legal guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve access to HIV prevention methods and screening for MSM and transgender individuals, potentially reducing new infections.
How similar studies have performed: Other studies have shown success in implementing PrEP programs and targeted screenings among similar populations, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cisgender men, transgender men, and transgender women reporting sexual relations with men * Age 18 years old * Accepting an STIs screening after contact through a geolocated community application or a physical place of community sociability * Given oral non-opposition to the anonymized use of the collected data Exclusion Criteria: * Planned stay in France \<1 month * Person under legal guardianship
Where this trial is running
Paris, Île-de-France
- Le SPOT — Paris, Île-de-France, France (Recruiting)
Study contacts
- Principal investigator: Michel Ohayon, Dr — Sexual Health Center 'Le 190'
- Study coordinator: Anton Eremin
- Email: anton.eremin@aphp.fr
- Phone: +33 01 42 16 01 42
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.